Commentary
Has tamoxifen had its day?
-
Correspondence: Michael Baum m.baum@ucl.ac.uk
Breast Cancer Res 2002, 4:213-217 doi:10.1186/bcr536
For a reply to this article, please see http://breast-cancer-research.com/inpress/bcr538
No comments have yet been made on this article.